Stepping Into the Executive Team – What Matters More Than You Expect

Joining an executive team is a defining moment.

It typically comes after years of strong performance, deep functional expertise, and increasing leadership responsibility. You’ve delivered results. You’ve built teams. You’ve earned trust.

But stepping into the executive team is not just a continuation of that trajectory, it’s a fundamental shift.

The expectations change immediately, and often in ways that are not explicitly stated. What made you successful before still matters, but it is no longer sufficient on its own.

Understanding that shift early is what separates executives who integrate quickly from those who struggle to find their footing.

The Shift From Function to Enterprise

Before joining the executive team, leaders are primarily measured by how effectively they run their function.

R&D leaders are evaluated on pipeline progress. Commercial leaders on revenue growth. Operations leaders on efficiency and scale.

Once you enter the executive team, that lens widens considerably.

You are no longer there to advocate solely for your function; you are there to make decisions in the best interest of the entire enterprise.

That means:

  • Supporting decisions that may not benefit your function in the short term
  • Balancing competing priorities across the organization
  • Thinking in terms of enterprise value, not functional optimization

In life sciences, where trade-offs often involve regulatory timelines, capital allocation, clinical risk, and commercialization strategy, this shift becomes even more pronounced.

Executives who succeed are the ones who embrace this broader mandate early, and demonstrate it consistently in how they think, speak, and decide.

Listening Comes Before Leading

There is often an unspoken pressure for new executives to “prove themselves” quickly. To make bold moves. To drive visible change. To show immediate impact. However, the most effective leaders take a different approach in their early months. They listen. They invest time in understanding:

  • How decisions get made (not just how they are supposed to be made)
  • The informal dynamics between executive team members
  • Where alignment is strong, and where it quietly breaks down
  • The historical context behind current strategies and sensitivities

In complex life sciences organizations, these dynamics are rarely obvious on the surface.

Leaders who move too quickly without this context often create unintended friction. Those who take the time to absorb, ask thoughtful questions, and map the landscape build a much stronger foundation for influence.

Early restraint is not a lack of leadership; it is a sign of maturity.

Credibility Is Built Through Consistency

In the first 90 to 180 days, everything is being evaluated. Not formally, but constantly. Your peers are watching:

  • How you communicate under pressure
  • How you handle disagreement in executive settings
  • Whether you follow through on commitments
  • How you balance advocacy with openness

Credibility at the executive level is not granted by title. It is earned through repeated, observable behavior where consistency matters more than speed.

Leaders who try to establish credibility through rapid action or sweeping changes often create noise without building trust. In contrast, those who demonstrate steady judgment, clear communication, and reliability over time become trusted voices in the room.

Once that credibility is established, influence follows naturally.

Relationships Define Effectiveness

Executive teams do not operate purely on logic; they operate on trust.

Without trust:

  • Alignment takes longer
  • Decisions become more political
  • Execution slows down across the organization

That’s why relationship-building at this level is not a “soft” priority, it is a strategic one.

High-performing executives invest early in:

  • One-on-one relationships with their peers
  • Understanding individual priorities, pressures, and motivations
  • Creating open lines of communication before moments of tension arise

In life sciences, where cross-functional collaboration is critical, think clinical, regulatory, manufacturing, and commercial alignment, these relationships directly impact outcomes.

Strong relationships reduce friction. They accelerate decision-making. They enable more honest and productive debate.

And over time, they become one of the most important drivers of effectiveness.

Making the Transition Count

Stepping into an executive role is not just a promotion, it is a transition into a different level of leadership.

The leaders who navigate it successfully recognize a few key truths early:

  • The role is no longer about individual excellence, but collective impact
  • Influence matters more than control
  • Alignment often matters more than being right
  • How you operate is just as important as what you deliver

This is especially true in life sciences, where complexity, risk, and long development cycles require tight coordination at the top.

Getting this transition right has a compounding effect. It shapes how quickly you integrate, how much influence you gain, and ultimately, how effective you can be in driving the organization forward.

At GeneCoda®, we work closely with life sciences executives at these critical transition points, whether they are stepping into new roles or building out leadership teams.

Time and again, the pattern is clear: leaders who prioritize alignment, relationships, and enterprise thinking early create far greater impact over the long term.

If you are preparing for, or currently navigating, this transition, the way you approach the first few months will shape everything that follows.

print